# Wellbutrin XL

### (bupropion XL)

<table border="1" id="bkmrk-prescribing-info" style="border-collapse: collapse; width: 100%; border-width: 0px; background-color: rgb(230, 126, 35);"><tbody><tr><td style="background-color: rgb(194, 224, 244); border-width: 0px; width: 50%;">[**Full Prescribing Information**](https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=a435da9d-f6e8-4ddc-897d-8cd2bf777b21&type=display)</td><td class="align-right" style="background-color: rgb(251, 238, 184); border-width: 0px; width: 50%;">[**DailyMed Drug Information**](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a435da9d-f6e8-4ddc-897d-8cd2bf777b21)</td></tr></tbody></table>

---

**Forms/Strengths**

- **Extended-release (XL):** 150 mg, 300 mg

---

### **Dosing**

- **Age:**
- **Onset:** ~60 min
- **Duration:** 8-12 hours
- **Considerations:** Monitor for neuropsychiatric symptoms, especially in children and adolescents.
- **Initial Dose:** 150 mg once daily
- **Titration:** Increase to 300 mg once daily after 3 days if tolerated
- **Max Dose:** 450 mg/day

---

### **Quick Facts**

- Inhibits reuptake of dopamine and norepinephrine; improves mood and energy
- Extended-release formulation for once-daily dosing and stable plasma levels
- Unique antidepressant profile; fewer sexual side effects and weight neutral
- Common side effects: dry mouth, insomnia, headache, nausea
- Caution: increased seizure risk at high doses or in susceptible individuals

---

### **Indications**

- **Major depressive disorder** (ICD-10: F32, F33)
- **Seasonal affective disorder** (ICD-10: F33.0)
- **Smoking cessation** (ICD-10: Z72.0)

---

### **Off-Label Uses**

- **Attention-deficit/hyperactivity disorder (ADHD)** (ICD-10: F90.0)

---

### **How to Take**

- Take **once daily in the morning** at the **same time each day**.
- Can be taken **with or without food**; taking with food may help reduce nausea.
- **Swallow the tablet whole**; do not crush, chew, or split.
- Avoid taking **close to bedtime**, as it may cause insomnia.
- **Do not abruptly stop** taking; tapering may be required to prevent withdrawal effects.

---

### **Side Effects**

- Common: Insomnia, dry mouth, headache, nausea
- Serious: Seizures, hypertension, neuropsychiatric symptoms

---

### **Monitoring / Labs**

- Blood pressure monitoring
- Monitor for worsening depression or suicidal thoughts

---

### **Education**

- **When to Call the Doctor:**
    
    
    - Severe **mood changes, aggression, or suicidal thoughts**.
    - Unexplained **seizures**, confusion, or hallucinations.
    - Signs of **allergic reaction** (rash, itching, swelling, difficulty breathing).
    - Unusual bruising or bleeding.
    - Severe headache, blurred vision, or persistent nausea (**signs of high blood pressure**).
- **Safety Tips:**
    
    
    - **Monitor mood and behavioral changes**, especially in patients with a history of depression or bipolar disorder.
    - Avoid **alcohol**, as it may increase the risk of seizures.
    - Use caution if you have a history of **seizures, eating disorders, or head trauma**, as Wellbutrin may lower the seizure threshold.
    - May cause **dry mouth**—increase hydration if needed.
    - Be cautious when driving or operating machinery until individual response is known.
- **Parent Tips for Pediatric Patients (if prescribed off-label):**
    
    
    - Monitor for **increased agitation, irritability, or changes in mood**.
    - Be aware of **appetite suppression**—encourage balanced meals.
    - Observe for **difficulty sleeping**; discuss timing adjustments with the provider if needed.

---

### **Additional Information**

- **Contraindications:**
    
    
    - **History of seizures or conditions that lower seizure threshold (e.g., eating disorders, head trauma, alcohol withdrawal).**
    - **Use within 14 days of MAOI therapy** (risk of hypertensive crisis).
    - **Severe hepatic impairment**, as it may increase drug accumulation.
- **Pregnancy:**
    
    
    - **Category C**; use only if benefits outweigh risks.
    - Limited human data, but potential risk for fetal harm is unclear.
- **Lactation:**
    
    
    - **Excreted in breast milk**; use with caution as effects on the infant are unknown.
- **Drug Interactions:**
    
    
    - **CYP2B6 inhibitors** (e.g., ticlopidine, clopidogrel) may increase Wellbutrin levels.
    - **CYP2B6 inducers** (e.g., carbamazepine, rifampin) may decrease effectiveness.
    - **Other medications that lower seizure threshold** (e.g., tramadol, antipsychotics, theophylline) may increase seizure risk.
    - **Serotonergic drugs** (e.g., SSRIs, SNRIs, MAOIs) may increase the risk of serotonin syndrome.